Treating life-threatening TAFRO syndrome with interleukin-1 inhibition

Volume: 87, Pages: 121 - 123
Published: May 1, 2021
Abstract
TAFRO syndrome (Thrombocytopenia, Anasarca, Fever, Reticulin fibrosis, and Organomegaly) is a newly recognized variant of idiopathic - human herpesvirus-8 (HHV-8) negative - Multicentric Castleman Disease (iMCD) [ [1] Iwaki N Fajgenbaum DC Nabel CS et al. Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease. Am J Hematol. 2016; 91: 220-226 Crossref PubMed Scopus (141)...
Paper Details
Title
Treating life-threatening TAFRO syndrome with interleukin-1 inhibition
Published Date
May 1, 2021
Volume
87
Pages
121 - 123
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.